In this study we evaluated serum concentrations of IL-17 in MM patients treated with BPs. BPs caused a significant decrease of IL17 levels while ONJ subjects showed a reduction of IL-17 levels with respect to controls, although they had interrupted BPs administration from several months.

Reduced serum levels of interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration

OTERI, Giacomo;ALLEGRA, Alessandro;ALONCI, Andrea;NASTRO SINISCALCHI, Enrico;CATALFAMO, Luciano Maria;CICCIU', Domenico;DE PONTE, Francesco Saverio;MUSOLINO, Caterina
2008-01-01

Abstract

In this study we evaluated serum concentrations of IL-17 in MM patients treated with BPs. BPs caused a significant decrease of IL17 levels while ONJ subjects showed a reduction of IL-17 levels with respect to controls, although they had interrupted BPs administration from several months.
2008
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/1890971
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 21
social impact